Key result
Enzymatically modified LDL markedly boosts arachidonic acid mobilization and inflammatory TNF-alpha secretion versus native LDL.
Why the study?
The cellular responses and molecular mechanisms underlying the atherogenic effects of lipolytically modified LDL are incompletely understood.
Answers are grounded in this paper and cite their sources.
Lipolytically modified LDL by sPLA2 or SMase potentiates arachidonic acid release and cPLA2 activation in human monocytes, suggesting novel atherogenic properties.
Oxidation and lipolytic remodeling of LDL are believed to stimulate LDL entrapment in the arterial wall, expanding the inflammatory response and promoting atherosclerosis. However, the cellular responses and molecular mechanisms underlying the atherogenic effects of lipolytically modified LDL are incompletely understood. Human THP-1 monocytes were prelabeled with [(3)H]arachidonic acid (AA) before incubation with LDL or LDL lipolytically modified by secretory PLA(2) (sPLA(2)) or bacterial sphingomyelinase (SMase). LDL elicited rapid and dose-dependent extracellular release of AA in monocytes. Interestingly, LDL modified by sPLA(2) or SMase displayed a marked increase in AA mobilization relative to native LDL, and this increase correlated with enhanced activity of cytosolic PLA(2) (cPLA(2)) assayed in vitro as well as increased monocyte tumor necrosis factor-alpha secretion. The AA liberation was attenuated by inhibitors toward cPLA(2) and sPLA(2), indicating that both PLA(2) enzymes participate in LDL-induced AA release. In conclusion, these results demonstrate that LDL lipolytically modified by sPLA(2) or SMase potentiates cellular AA release and cPLA(2) activation in human monocytes. From our results, we suggest novel atherogenic properties for LDL modified by sPLA(2) and SMase in AA release and signaling, which could contribute to the inflammatory gene expression observed in atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Oestvang et al. (2004) studied Atherosclerosis. LDL lipolytically modified by secretory PLA2 (sPLA2) or bacterial sphingomyelinase (SMase) vs. Native LDL was evaluated on Extracellular release of arachidonic acid (AA) and cPLA2 activation. LDL modified by sPLA2 or SMase displayed a marked increase in arachidonic acid mobilization relative to native LDL, correlating with enhanced cPLA2 activity and TNF-alpha secretion.
Synapse has enriched 10 related papers. Consider them for comparative context: